Retail subscription to 2.66M shares of Almoosa Health starts on TASI today

09:46 AM (Mecca time) Argaam Special
Oneof Almoosa Health Co.'s hospitals

One of Almoosa Health Co.'s hospitals


Retail investors began subscribing today, Dec. 23, to 2.66 million shares of Almoosa Health Co. at SAR 127 per share, as determined through the book-building process.

 

The retail tranche accounts for 20% of the total offering, with the subscription running for two days until Dec. 24.

 

For More IPOs

 

In September, the Capital Market Authority (CMA) approved Almoosa’s request to float 13.29 million shares, or 30% of the post-IPO capital, on the Main Market (TASI). The offering also represents 37.97% of the pre-IPO capital, with a nominal value per share of SAR 10.

 

The company’s institutional offering ended last week, with a coverage ratio of 103x.

 

Almoosa’s IPO is the 13th this year, following listings by after Middle East Pharmaceutical Industries Co. (Avalon Pharma) on Jan. 30, Modern Mills for Food Products Co. on March 5, Miahona Co. and Dr. Soliman Abdulkader Fakeeh Hospital Co. (Fakeeh Care) on May 21, Saudi Manpower Solutions Co. (SMASCO) on May 26, Al Taiseer Group Talco Industrial Co. (TALCO) on May 28, Rasan Information Technology Co. on May 29, Almajed for Oud Co. on Sept. 15, Arabian Mills Co. on Sept. 18, Fourth Milling Co. (MC4) on Oct. 2, Tamkeen Human Resources Co. on Nov. 5, and United International Holding Co. on Nov. 19.


Tadawul witnessed eight IPOs in 2023, including MBC Holding Group Ltd.Morabaha Marina and Mawarid Manpower Co.Jamjoom Pharmaceuticals Factory Co.First Milling Co.Lumi Rental Co.ADES Holding Co., and SAL Saudi Logistics Services Co.

 

Key Background

 

Almoosa Health started its operations in 1994 as a branch of Abdulaziz Abdullah Abdulwahab Al-Moosa Trading Establishment under the name "Almoosa Specialist Hospital (Al-Ahsa)".

 

The company transformed into a limited liability company in 2018 and later became a closed joint-stock company in 2020.

 

Almoosa's pre-IPO capital reaches SAR 350 million, divided into 35 million shares, at a nominal value of SAR 10 each. The company's post-IPO capital will reach SAR 443.04 million, divided into 44.3 million shares.

 

The company operates primarily in the healthcare sector, providing integrated healthcare services, including primary care, critical care, and rehabilitation services at Almoosa Specialist Hospital (Al-Ahsa) and Almoosa Rehabilitation Hospital, Al-Ahsa. It also provides secondary services to this sector, such as pharmaceutical services, home healthcare, and telemedicine.

 

The company's hospitals, Almoosa Specialist Hospital in Al-Ahsa and Al Ahsa Hospital, focus exclusively on serving the Eastern Province. In 2023, they provided 9.3% and 4.8%, respectively, of the critical care beds available in the private sector in the region.

 

According to the prospectus, Almoosa Health owns 22 land plots and holds 44 lease contracts as a tenant, primarily for employee housing. Additionally, it has two lease contracts for establishing a primary healthcare center and one lease contract for a company warehouse.

 

Company Hospitals:

 

Almoosa Health has 730 beds across its hospitals in the Eastern Province and offers a comprehensive range of healthcare services.

 

The company also provides healthcare services to approximately one million patients annually, supported by a team of more than 2,900 employees, including 326 experienced physicians.

 

The company's total number of clinics is 290, as shown below:

 

Hospitals’ operational information by March 2024

Details

Almoosa Specialist Hospital (Al-Ahsa)

Almoosa Rehabilitation Hospital

Total

Land Area (‘000 m²)

14.1

25.6

111.8

Built-up Area (‘000 m²)

110

100

210

No. of Clinics

245

45

290

No. of Employees

2,696

376

3,072

No. of  Physicians

300

26

326

No. of Beds

430

300

730

 

Company’s Revenue:

 

Almoosa’s revenue increased by approximately 20% to about SAR 979 million in 2023, compared to more than SAR 816 million in 2022.

 

According to the prospectus, income from medical services accounts for 81% of total revenue during the period, while revenue from pharmaceuticals represents 19%, as shown in the following table:

 

Revenue by Main Services (SAR mln)

Service

2022 

2023 

Change

% of Total

Medical Services

661.4

792.3

+20%

81%

Pharmaceuticals

155

186.7

+20%

19 %

Total

816

979

+20%

100%

 

Workforce

 

The number of employees at Almoosa reached 2,922 by the end of March 2024, of whom 1,275 are Saudi citizens, representing a Saudization rate of approximately 44%.

 

Employees by Main Activitand Saudization Rates

Section

Citizens

Non-citizens

Total

Executive Management

5

9

14

Administrative Employees

517

257

774

Nursing

137

774

911

Medical Staff

49

274

323

Support Health Technicians

447

156

603

Support and Assistance Departments

120

177

297

Total

1,275

1,647

2,922

 

Branches:

 

The company has seven branches in the Eastern Province of the Kingdom, as shown below:

 

Company Branches

 

Location

Activity

1

Al-Mubarraz

Pharmacies

2

Al-Mubarraz

Medical Supplies Warehouses

3

Al-Ahsa

Home Healthcare Services

4

Al-Ahsa

Rehabilitation Centers

5

Al-Mubarraz

Restaurants

6

Al-Ahsa

Sports Clubs

7

Al-Mubarraz

Pharmaceutical Warehouses

 

Future Plans and Initiatives:

 

The company plans to expand its operations in the Eastern Province, as it is working on designing, constructing, and developing two specialized hospitals in Al Khobar and Al-Ahsa, in addition to five primary healthcare centers in Al-Ahsa, Al Khobar, and Dammam, which are still under construction.

 

Future Projects

Project

Land Area
(‘000 m²)

Built-up Area
(‘000 m²)

Capacity

Location

Expected Inauguration

Almoosa Specialist Hospital (Al Khobar)

45

300

400 Beds,
Multiple centers of Excellence,
300 Clinics and One Pharmacy

New Khobar Corniche in the Al-Bahr District

Q1 2028

Almoosa Specialist Hospital (Al Hofuf)

150

--

300 beds, 200 clinics and one pharmacy

Al Hofuf City, the capital of Al-Ahsa governorate

Q2 2027

5 Primary Care Centers

One pharmacy

Al-Ahsa

Q2 2025

One pharmacy

Al-Ahsa

Q4 2025

One pharmacy

Al-Ahsa

Q2 2027

One pharmacy

Al Khobar

Q1 2026

One pharmacy

Al-Dammam

Q4 2027

 

Company Profile

Company

Almoosa Health Group

Market

Tadawul

Core Activities

Healthcare

Pre-IPO Capital

SAR 350 mln

Capital after IPO

SAR 443.04 mln

Number of Shares

35 mln

Number of Shares after IPO

44.30 mln

Share Par Value

SAR 10/share

 

IPO Summary

Issue Percentage

30% of capital

Issue Price

SAR 127

Number of Shares Offered

2.66 million shares (20% of total offering)

Qualified Subscribers

Individuals

IPO Minimum Limit for Retail Investors

10 shares

Maximum Limit for Retail Investors

250,000 shares

Retail Offering

From Dec. 23- 24, 2024

Final Allocation

Dec. 29, 2024

Refund (if any)

Jan. 2, 2025

 

Additional Information

Financial Advisor and Lead Manager

Saudi Fransi Capital

Institutional Bookrunners & Underwriters

EFG Hermes Saudi Arabia, Saudi Fransi Capital

Receiving banks

SNB Capital, SAB Invest, Al Rajhi Capital, Saudi Fransi Capital, Alinma Investment, Riyad Capital, AlJazira Capital, Alistithmar Capital, Albilad Capital, ANB Capital, Derayah Financial, Yaqeen Capital, Alkhabeer Capital and Sahm Capital

 

Major Shareholders

Shareholders

Before IPO

After IPO

Number of Shares

(mln shares)

Ownership (%)

Number of Shares

(mln shares)

Ownership (%)

Abdulaziz bin Abdullah AlMoosa Investment Co.

33.25

95.00%

29.13

65.75%

Abdulaziz Abdullah AlMoosa Charitable Co.

1.75

5.00%

1.75

3.95%

Public

--

--

13.29

30.00%

Total

35.00

100%

44.30

100%

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.